Applied DNA Sciences, Inc. (APDN)
USD 0.89
(-2.09%)
USD 0.89
(-2.09%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -15.21 USD | 18.58% |
| 2022 | -18.68 USD | 59.7% |
| 2021 | -46.35 USD | 28.85% |
| 2020 | -65.14 USD | 65.22% |
| 2019 | -187.30 USD | 40.94% |
| 2018 | -317.12 USD | 18.66% |
| 2017 | -389.88 USD | 5.17% |
| 2016 | -411.13 USD | 18.08% |
| 2015 | -501.89 USD | 35.11% |
| 2014 | -773.45 USD | 35.87% |
| 2013 | -1206.12 USD | -3940.6% |
| 2012 | -29.85 USD | 55.43% |
| 2011 | -66.97 USD | -5.97% |
| 2010 | -63.20 USD | -231.67% |
| 2009 | 48.00 USD | 156.3% |
| 2008 | -85.26 USD | 63.89% |
| 2007 | -236.13 USD | -377.22% |
| 2006 | -49.48 USD | 97.5% |
| 2005 | -1975.46 USD | 11.47% |
| 2004 | -2231.50 USD | -249.64% |
| 2003 | -638.23 USD | -8666.9% |
| 2002 | -7.28 USD | 92.36% |
| 2001 | -95.33 USD | -70.54% |
| 2000 | -55.90 USD | -111.98% |
| 1999 | -26.37 USD | -236.78% |
| 1998 | -7.83 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -5.13 USD | -185.0% |
| 2024 Q1 | -1.80 USD | 65.97% |
| 2024 Q3 | 0.47 USD | 109.16% |
| 2023 Q1 | -6.00 USD | -337.96% |
| 2023 FY | - USD | 18.58% |
| 2023 Q3 | -4.80 USD | -627.47% |
| 2023 Q2 | 0.91 USD | 115.17% |
| 2023 Q4 | -5.29 USD | -10.21% |
| 2022 Q2 | -2.79 USD | 77.87% |
| 2022 Q3 | -0.13 USD | 95.34% |
| 2022 Q1 | -12.61 USD | -4.73% |
| 2022 FY | - USD | 59.7% |
| 2022 Q4 | -1.37 USD | -953.85% |
| 2021 FY | - USD | 28.85% |
| 2021 Q1 | -17.62 USD | -9.85% |
| 2021 Q2 | -4.19 USD | 76.22% |
| 2021 Q3 | -9.53 USD | -127.45% |
| 2021 Q4 | -12.04 USD | -26.34% |
| 2020 Q2 | -15.71 USD | 29.77% |
| 2020 Q1 | -22.37 USD | 2.74% |
| 2020 FY | - USD | 65.22% |
| 2020 Q4 | -16.04 USD | -11.62% |
| 2020 Q3 | -14.37 USD | 8.53% |
| 2019 FY | - USD | 40.94% |
| 2019 Q3 | -31.02 USD | 51.79% |
| 2019 Q4 | -23.00 USD | 25.85% |
| 2019 Q1 | -84.92 USD | 8.01% |
| 2019 Q2 | -64.35 USD | 24.22% |
| 2018 Q2 | -57.02 USD | 38.04% |
| 2018 Q3 | -76.72 USD | -34.55% |
| 2018 Q4 | -92.31 USD | -20.32% |
| 2018 Q1 | -92.03 USD | -10.32% |
| 2018 FY | - USD | 18.66% |
| 2017 Q4 | -83.42 USD | -5.34% |
| 2017 FY | - USD | 5.17% |
| 2017 Q3 | -79.19 USD | 23.93% |
| 2017 Q2 | -104.10 USD | 16.47% |
| 2017 Q1 | -124.63 USD | -55.32% |
| 2016 Q1 | -103.85 USD | -462.26% |
| 2016 FY | - USD | 18.08% |
| 2016 Q2 | -115.24 USD | -10.97% |
| 2016 Q3 | -111.88 USD | 2.92% |
| 2016 Q4 | -80.24 USD | 28.28% |
| 2015 Q3 | -62.33 USD | 28.26% |
| 2015 Q4 | -18.47 USD | 70.37% |
| 2015 FY | - USD | 35.11% |
| 2015 Q2 | -86.88 USD | 78.56% |
| 2015 Q1 | -405.19 USD | -233.38% |
| 2014 Q4 | -121.54 USD | -7.42% |
| 2014 FY | - USD | 35.87% |
| 2014 Q1 | -382.33 USD | -63.73% |
| 2014 Q2 | -163.34 USD | 57.28% |
| 2014 Q3 | -113.14 USD | 30.73% |
| 2013 FY | - USD | -3940.6% |
| 2013 Q1 | -32.14 USD | -378.99% |
| 2013 Q2 | -220.64 USD | -586.5% |
| 2013 Q4 | -233.51 USD | -64.27% |
| 2013 Q3 | -142.15 USD | 35.57% |
| 2012 FY | - USD | 55.43% |
| 2012 Q4 | -6.71 USD | -16.29% |
| 2012 Q3 | -5.77 USD | 9.13% |
| 2012 Q2 | -6.35 USD | 46.19% |
| 2012 Q1 | -11.80 USD | 49.38% |
| 2011 Q3 | -14.69 USD | 17.24% |
| 2011 Q4 | -23.31 USD | -58.68% |
| 2011 FY | - USD | -5.97% |
| 2011 Q1 | -9.24 USD | 38.32% |
| 2011 Q2 | -17.75 USD | -92.1% |
| 2010 FY | - USD | -231.67% |
| 2010 Q1 | -15.77 USD | -22.92% |
| 2010 Q2 | -11.67 USD | 26.0% |
| 2010 Q4 | -14.98 USD | 27.56% |
| 2010 Q3 | -20.68 USD | -77.21% |
| 2009 Q2 | 96.00 USD | 368.61% |
| 2009 Q1 | -35.74 USD | -63.64% |
| 2009 Q4 | -12.83 USD | -4.99% |
| 2009 FY | - USD | 156.3% |
| 2009 Q3 | -12.22 USD | -112.73% |
| 2008 Q4 | -21.84 USD | -14.77% |
| 2008 Q3 | -19.03 USD | 0.68% |
| 2008 Q2 | -19.16 USD | 31.81% |
| 2008 Q1 | -28.10 USD | 61.59% |
| 2008 FY | - USD | 63.89% |
| 2007 FY | - USD | -377.22% |
| 2007 Q4 | -73.15 USD | -404.79% |
| 2007 Q3 | 24.00 USD | 112.93% |
| 2007 Q2 | -185.60 USD | -1294.44% |
| 2007 Q1 | -13.31 USD | 88.65% |
| 2006 Q1 | -110.69 USD | 75.1% |
| 2006 Q4 | -117.29 USD | -106527.27% |
| 2006 Q3 | -0.11 USD | -100.23% |
| 2006 Q2 | 48.00 USD | 143.36% |
| 2006 FY | - USD | 97.5% |
| 2005 Q3 | -100.37 USD | 83.91% |
| 2005 Q1 | -1083.05 USD | -43.85% |
| 2005 Q2 | -623.92 USD | 42.39% |
| 2005 FY | - USD | 11.47% |
| 2005 Q4 | -444.61 USD | -342.97% |
| 2004 Q2 | -282.51 USD | 71.13% |
| 2004 Q1 | -978.40 USD | -187.87% |
| 2004 Q3 | -250.80 USD | 11.22% |
| 2004 Q4 | -752.90 USD | -200.2% |
| 2004 FY | - USD | -249.64% |
| 2003 Q1 | -33.98 USD | 0.0% |
| 2003 Q3 | -46.57 USD | 15.13% |
| 2003 Q4 | -339.88 USD | -629.83% |
| 2003 FY | - USD | -8666.9% |
| 2003 Q2 | -54.87 USD | -61.48% |
| 2002 Q1 | -0.05 USD | 97.42% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 100.0% |
| 2002 FY | - USD | 92.36% |
| 2001 Q3 | -1.75 USD | -4.79% |
| 2001 Q1 | -85.98 USD | -2766.0% |
| 2001 FY | - USD | -70.54% |
| 2001 Q4 | -1.93 USD | -10.29% |
| 2001 Q2 | -1.67 USD | 98.06% |
| 2000 Q4 | -3.00 USD | -13.21% |
| 2000 FY | - USD | -111.98% |
| 2000 Q2 | -3.70 USD | 92.69% |
| 2000 Q3 | -2.65 USD | 28.38% |
| 2000 Q1 | -50.62 USD | 0.0% |
| 1999 Q2 | -2.65 USD | 0.0% |
| 1999 Q3 | -2.63 USD | 0.75% |
| 1999 Q4 | - USD | 100.0% |
| 1999 FY | - USD | -236.78% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -1097.638% |
| Aspira Women's Health Inc. | -1.81 USD | -740.331% |
| Biodesix, Inc. | -0.64 USD | -2276.563% |
| BioNexus Gene Lab Corp. | -0.17 USD | -8847.059% |
| bioAffinity Technologies, Inc. | -0.91 USD | -1571.429% |
| bioAffinity Technologies, Inc. | -0.91 USD | -1571.429% |
| Bionano Genomics, Inc. | -6.81 USD | -123.348% |
| CareDx, Inc | -3.54 USD | -329.661% |
| Check-Cap Ltd. | -3.00 USD | -407.0% |
| Castle Biosciences, Inc. | -2.14 USD | -610.748% |
| DarioHealth Corp. | -1.93 USD | -688.083% |
| Exact Sciences Corporation | -1.13 USD | -1246.018% |
| Fulgent Genetics, Inc. | -5.63 USD | -170.16% |
| Guardant Health, Inc. | -4.28 USD | -255.374% |
| ICON Public Limited Company | 7.46 USD | 303.887% |
| IDEXX Laboratories, Inc. | 10.17 USD | 249.558% |
| Illumina, Inc. | -7.35 USD | -106.939% |
| Intelligent Bio Solutions Inc. | -6.38 USD | -138.401% |
| iSpecimen Inc. | -1.23 USD | -1136.585% |
| Standard BioTools Inc. | -0.94 USD | -1518.085% |
| MDxHealth SA | -1.66 USD | -816.265% |
| 23andMe Holding Co. | -1.40 USD | -986.429% |
| Medpace Holdings, Inc. | 9.20 USD | 265.326% |
| Myriad Genetics, Inc. | -1.39 USD | -994.245% |
| Mainz Biomed B.V. | -1.62 USD | -838.889% |
| ENDRA Life Sciences Inc. | -1.11 USD | -1270.27% |
| NeoGenomics, Inc. | -0.70 USD | -2072.857% |
| Neogen Corporation | -0.04 USD | -34865.517% |
| Inotiv, Inc. | -4.10 USD | -270.976% |
| Natera, Inc. | -3.78 USD | -302.381% |
| OPKO Health, Inc. | -0.25 USD | -5984.0% |
| Psychemedics Corporation | -0.72 USD | -2012.5% |
| Prenetics Global Limited | -5.58 USD | -172.581% |
| Prenetics Global Limited | -5.58 USD | -172.581% |
| Precipio, Inc. | -4.51 USD | -237.251% |
| Personalis, Inc. | -2.25 USD | -576.0% |
| RadNet, Inc. | 0.05 USD | 31853.653% |
| Sera Prognostics, Inc. | -1.16 USD | -1211.207% |
| Sotera Health Company | 0.18 USD | 8550.0% |
| Neuronetics, Inc. | -1.05 USD | -1348.571% |
| Star Equity Holdings, Inc. | 7.42 USD | 304.987% |
| Star Equity Holdings, Inc. | 7.42 USD | 304.987% |
| Trinity Biotech plc | -3.14 USD | -384.395% |
| Twist Bioscience Corporation | -3.60 USD | -322.5% |
| Exagen Inc. | -1.34 USD | -1035.075% |